NASDAQ:LIPO

Lipella Pharmaceuticals (LIPO) Stock Price, News & Analysis

$0.72
+0.00 (+0.20%)
(As of 09:51 AM ET)
Today's Range
$0.72
$0.72
50-Day Range
$0.67
$1.04
52-Week Range
$0.64
$2.71
Volume
176 shs
Average Volume
50,850 shs
Market Capitalization
$4.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

Lipella Pharmaceuticals MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
178.7% Upside
$2.00 Price Target
Short Interest
Healthy
1.24% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$23,700 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.50 out of 5 stars

LIPO stock logo

About Lipella Pharmaceuticals Stock (NASDAQ:LIPO)

Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.

LIPO Stock Price History

LIPO Stock News Headlines

How to camouflage a factory of 53,000 workers
"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."
How to camouflage a factory of 53,000 workers
"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."
Lipella Pharma's IND Application For LP-410 Gets FDA's Approval
Lipella Pharmaceuticals Inc Ordinary Shares LIPO
Lipella Pharmaceuticals Inc. (LIPO)
Lipella Pharmaceuticals Inc Ordinary Shares
See More Headlines
Receive LIPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lipella Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/24/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LIPO
Fax
N/A
Employees
5
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.00
High Stock Price Target
$2.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+178.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-4,620,000.00
Net Margins
-1,025.93%
Pretax Margin
-1,026.44%

Debt

Sales & Book Value

Annual Sales
$450,000.00
Book Value
$0.54 per share

Miscellaneous

Free Float
3,776,000
Market Cap
$4.48 million
Optionable
Not Optionable
Beta
1.33
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Dr. Jonathan Kaufman M.B.A. (Age 57)
    Ph.D., Co-Founder, Chairman, CEO, President, Secretary & Treasurer
    Comp: $204.13k
  • Dr. Michael B. Chancellor M.D. (Age 65)
    Co-Founder, Chief Medical Officer & Director
    Comp: $195.83k
  • Mr. Douglas Johnston CPA (Age 39)
    Chief Financial Officer
    Comp: $185k
  • Ms. Michele Gruber
    Director of Operations
  • Katie Johnston
    Controller

LIPO Stock Analysis - Frequently Asked Questions

Should I buy or sell Lipella Pharmaceuticals stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Lipella Pharmaceuticals in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LIPO shares.
View LIPO analyst ratings
or view top-rated stocks.

What is Lipella Pharmaceuticals' stock price target for 2024?

1 Wall Street research analysts have issued 12-month price targets for Lipella Pharmaceuticals' stock. Their LIPO share price targets range from $2.00 to $2.00. On average, they expect the company's stock price to reach $2.00 in the next year. This suggests a possible upside of 178.7% from the stock's current price.
View analysts price targets for LIPO
or view top-rated stocks among Wall Street analysts.

How have LIPO shares performed in 2024?

Lipella Pharmaceuticals' stock was trading at $1.02 at the start of the year. Since then, LIPO shares have decreased by 29.7% and is now trading at $0.7175.
View the best growth stocks for 2024 here
.

Are investors shorting Lipella Pharmaceuticals?

Lipella Pharmaceuticals saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 43,700 shares, a drop of 17.7% from the March 15th total of 53,100 shares. Based on an average daily trading volume, of 57,100 shares, the short-interest ratio is currently 0.8 days. Currently, 1.2% of the company's shares are sold short.
View Lipella Pharmaceuticals' Short Interest
.

When is Lipella Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our LIPO earnings forecast
.

When did Lipella Pharmaceuticals IPO?

Lipella Pharmaceuticals (LIPO) raised $7 million in an initial public offering (IPO) on Tuesday, December 20th 2022. The company issued 1,217,391 shares at a price of $5.75 per share.

How do I buy shares of Lipella Pharmaceuticals?

Shares of LIPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LIPO) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners